Electra Therapeutics, Inc. (ETRA)
Electra Therapeutics, Inc. is a clinical stage biotechnology company. It is engaged in therapies against novel targets for diseases in immunology and cancer. The company was founded by Adam Rosenthal on October 11, 2018 and is headquartered in South San Francisco, CA.
Sector: Biological Products, (No Diagnostic Substances)
Industry: Medical - Pharmaceuticals
Electra Therapeutics Inc.
Trials need funding. See this company's dilution risk and cash position.
- Phase 2/3Recruiting
Open-label Study of ELA026 in Participants With Secondary Hemophagocytic Lymphohistiocytosis (sHLH)
ELA026
Secondary Hemophagocytic Lymphohistiocytosis (sHLH)
NCT05416307Enrollment156StartMay 2022Primary CompletionMar 2028est.CompletionMar 2030est. - Phase 1Completed
Evaluation of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ELA026 in Single and Multiple Doses in Healthy Volunteers
ELA026, ELA026
Healthy Volunteers
NCT05556863Enrollment91StartOct 2021Primary CompletionNov 2023CompletionNov 2023 - Phase 1Recruiting
A Study of ELA026 in Participants With Relapsed/Refractory (R/R) T/NK Cell Malignancies (TCMs)
ELA026
T Cell Malignancies
NCT07465835Enrollment84StartFeb 2026Primary CompletionJun 2028est.CompletionDec 2028est.
| Drug / Therapy | Link | ||
|---|---|---|---|
| Phase 2/3 | Recruiting | ELA026 | NCT05416307 |
| Phase 1 | Completed | ELA026, ELA026 | NCT05556863 |
| Phase 1 | Recruiting | ELA026 | NCT07465835 |